32 |
· Compound K, a metabolite of ginsenosides, induces cardiac protection mediated nitric oxide via Akt/PI3K pathway · Akt/PI
mginbiocorp
|
2019.05.14
|
추천 0
|
조회 6076
|
mginbiocorp |
2019.05.14 |
0 |
6076 |
31 |
· Subchronic toxicity studies with ginsenoside compound K delivered to dogs via intravenous administration · 개에게 정맥내투여를 통하
mginbiocorp
|
2019.05.14
|
추천 0
|
조회 6866
|
mginbiocorp |
2019.05.14 |
0 |
6866 |
30 |
· Ginsenoside metabolites, rather than naturally occurring ginsenosides, lead to inhibition of human cytochrome P450 enzymes
mginbiocorp
|
2019.05.14
|
추천 0
|
조회 6740
|
mginbiocorp |
2019.05.14 |
0 |
6740 |
29 |
· Hepatoprotective effect of ginsenoside Rb1 and compound K on tert-butyl hydroperoxide-induced liver injury · 간 손상에서 gins
mginbiocorp
|
2019.05.14
|
추천 0
|
조회 6624
|
mginbiocorp |
2019.05.14 |
0 |
6624 |
28 |
· Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5′monophosphate kinase: A study i
mginbiocorp
|
2019.05.14
|
추천 0
|
조회 10111
|
mginbiocorp |
2019.05.14 |
0 |
10111 |
27 |
· Ginsenoside Rb1 and compound K improve insulin signaling and inhibit ER stress-associated NLRP3 inflammasome activation
mginbiocorp
|
2019.05.14
|
추천 0
|
조회 9708
|
mginbiocorp |
2019.05.14 |
0 |
9708 |
26 |
· Hypoglycemic effect of protopanaxadiol-type ginsenosides and compound K on Type 2 Diabetes mice induced by High-Fat Diet
mginbiocorp
|
2019.05.14
|
추천 0
|
조회 10121
|
mginbiocorp |
2019.05.14 |
0 |
10121 |
25 |
· Compound K protects MIN6N8 pancreatic β‐cells against palmitate‐induced apoptosis through modulating SAPK/JNK activation
mginbiocorp
|
2019.05.14
|
추천 0
|
조회 9745
|
mginbiocorp |
2019.05.14 |
0 |
9745 |
24 |
· Anti-diabetic effects of compound K versus metformin versus compound K-metformin combination therapy in diabetic db/db mice |
mginbiocorp |
2019.05.14 |
0 |
10073 |
23 |
· Compound K enhances insulin secretion with beneficial metabolic effects in db/db mice · db/db Mice에서 인슐린 분비 조절 기능에 관여하는
mginbiocorp
|
2019.05.14
|
추천 0
|
조회 9975
|
mginbiocorp |
2019.05.14 |
0 |
9975 |